A Literature Review on the Role of Adipocytokines in Breast Cancer and Metabolic Syndrome

Adipocytokines, bioactive molecules secreted by adipose tissue, have emerged as critical regulators of physiological processes and key contributors to the pathogenesis of various diseases. The relationship between adipocytokines, breast cancer (BC), and metabolic syndrome (MetS) represents a complex network involving intricate signaling pathways, such as those governing inflammation, insulin resistance, and angiogenesis. Understanding the dual role of specific adipocytokines in both promoting and inhibiting BC progression, while also influencing MetS development, provides valuable insights. This review synthesizes current literature, illuminating the molecular mechanisms underlying these associations, highlighting their potential as biomarkers and therapeutic targets, and emphasizing the need for integrated strategies to manage the interconnected risks of BC and MetS. Further research focusing on specific BC subtypes and longitudinal studies is crucial for translating these findings into clinical practice.